Switching from prednisone to dexamethasone in metastatic castration resistant prostate cancer treated with abiraterone acetate in a multicenter study by I. Rivero Belenchón, C. Muñoz Calahorro, I. Osmán García, P. Beardo Villar, C.B. Congregado Ruíz, B. San José Ruíz Jiménez, J. Campé Bartolo, R. Llarena Ibarguren, J. Extramina Cameno, R.A. Medina López

Get full text